Annual EBITDA
-$1.26 M
+$135.20 M+99.08%
December 31, 2024
Summary
- As of March 8, 2025, WGS annual EBITDA is -$1.26 million, with the most recent change of +$135.20 million (+99.08%) on December 31, 2024.
- During the last 3 years, WGS annual EBITDA has risen by +$219.49 million (+99.43%).
- WGS annual EBITDA is now at all-time high.
Performance
WGS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$14.36 M
+$16.21 M+876.01%
December 31, 2024
Summary
- As of March 8, 2025, WGS quarterly EBITDA is $14.36 million, with the most recent change of +$16.21 million (+876.01%) on December 31, 2024.
- Over the past year, WGS quarterly EBITDA has increased by +$33.91 million (+173.48%).
- WGS quarterly EBITDA is now -63.08% below its all-time high of $38.91 million, reached on September 1, 2021.
Performance
WGS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$25.21 M
+$33.91 M+57.36%
December 31, 2024
Summary
- As of March 8, 2025, WGS TTM EBITDA is -$25.21 million, with the most recent change of +$33.91 million (+57.36%) on December 31, 2024.
- Over the past year, WGS TTM EBITDA has increased by +$114.10 million (+81.90%).
- WGS TTM EBITDA is now at all-time high.
Performance
WGS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
WGS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +99.1% | +173.5% | +81.9% |
| 3 y3 years | +99.4% | +173.5% | +81.9% |
| 5 y5 years | +94.4% | +173.5% | +81.9% |
WGS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +99.7% | at high | +111.5% | at high | +92.9% |
| 5 y | 5-year | at high | +99.7% | -63.1% | +107.7% | at high | +93.8% |
| alltime | all time | at high | +99.7% | -63.1% | +107.7% | at high | +93.8% |
GeneDx Holdings EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$1.26 M(-99.1%) | $14.36 M(-876.0%) | -$25.21 M(-57.4%) |
| Sep 2024 | - | -$1.85 M(-92.0%) | -$59.13 M(-29.0%) |
| Jun 2024 | - | -$23.25 M(+60.6%) | -$83.29 M(-17.8%) |
| Mar 2024 | - | -$14.48 M(-26.0%) | -$101.33 M(-27.3%) |
| Dec 2023 | -$136.46 M(-65.7%) | -$19.55 M(-24.8%) | -$139.32 M(-30.5%) |
| Sep 2023 | - | -$26.01 M(-37.0%) | -$200.47 M(-21.3%) |
| Jun 2023 | - | -$41.29 M(-21.3%) | -$254.77 M(-24.7%) |
| Mar 2023 | - | -$52.47 M(-35.0%) | -$338.54 M(-5.0%) |
| Dec 2022 | -$398.20 M | -$80.70 M(+0.5%) | -$356.36 M(+15.2%) |
| Sep 2022 | - | -$80.31 M(-35.8%) | -$309.35 M(+62.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$125.06 M(+77.9%) | -$190.13 M(+81.3%) |
| Mar 2022 | - | -$70.28 M(+108.7%) | -$104.88 M(-52.5%) |
| Dec 2021 | -$220.75 M(-2.8%) | - | - |
| Dec 2021 | - | -$33.68 M(-186.6%) | -$220.75 M(-28.4%) |
| Sep 2021 | - | $38.91 M(-197.7%) | -$308.51 M(-23.5%) |
| Jun 2021 | - | -$39.82 M(-78.6%) | -$403.40 M(+11.0%) |
| Mar 2021 | - | -$186.15 M(+53.3%) | -$363.58 M(+104.9%) |
| Dec 2020 | -$227.13 M(+908.8%) | -$121.45 M(+117.0%) | -$177.43 M(+217.0%) |
| Sep 2020 | - | -$55.98 M | -$55.98 M |
| Dec 2019 | -$22.51 M | - | - |
FAQ
- What is GeneDx Holdings annual EBITDA?
- What is the all time high annual EBITDA for GeneDx Holdings?
- What is GeneDx Holdings annual EBITDA year-on-year change?
- What is GeneDx Holdings quarterly EBITDA?
- What is the all time high quarterly EBITDA for GeneDx Holdings?
- What is GeneDx Holdings quarterly EBITDA year-on-year change?
- What is GeneDx Holdings TTM EBITDA?
- What is the all time high TTM EBITDA for GeneDx Holdings?
- What is GeneDx Holdings TTM EBITDA year-on-year change?
What is GeneDx Holdings annual EBITDA?
The current annual EBITDA of WGS is -$1.26 M
What is the all time high annual EBITDA for GeneDx Holdings?
GeneDx Holdings all-time high annual EBITDA is -$1.26 M
What is GeneDx Holdings annual EBITDA year-on-year change?
Over the past year, WGS annual EBITDA has changed by +$135.20 M (+99.08%)
What is GeneDx Holdings quarterly EBITDA?
The current quarterly EBITDA of WGS is $14.36 M
What is the all time high quarterly EBITDA for GeneDx Holdings?
GeneDx Holdings all-time high quarterly EBITDA is $38.91 M
What is GeneDx Holdings quarterly EBITDA year-on-year change?
Over the past year, WGS quarterly EBITDA has changed by +$33.91 M (+173.48%)
What is GeneDx Holdings TTM EBITDA?
The current TTM EBITDA of WGS is -$25.21 M
What is the all time high TTM EBITDA for GeneDx Holdings?
GeneDx Holdings all-time high TTM EBITDA is -$25.21 M
What is GeneDx Holdings TTM EBITDA year-on-year change?
Over the past year, WGS TTM EBITDA has changed by +$114.10 M (+81.90%)